Literature DB >> 4542733

Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities.

T S Zimmerman, T S Edgington.   

Abstract

Factor VIII coagulant activity (VIII(C)) and the von Willebrand's disease antigen (Factor VIII-like antigen, vW-Ag) are biologically linked, and it has been suggested that they reside on the same molecule. However, insolubilized human isoantibody to VIII(C) and rabbit antiserum containing antibodies to VIII(C) and vW-Ag differentially bind and remove these entities from plasma, thus physically segregating one from the other. These findings indicate that Factor VIII coagulant activity resides on a molecule distinct from that expressing the von Willebrand's antigen.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4542733      PMCID: PMC2180567          DOI: 10.1084/jem.138.4.1015

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Assay of the immune inhibitor in classic haemophilia: application of virus-antibody reaction kinetics.

Authors:  J G Pool; R G Miller
Journal:  Br J Haematol       Date:  1972-05       Impact factor: 6.998

2.  Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease.

Authors:  B N Bouma; Y Wiegerinck; J J Sixma; J A Van Mourik; I A Mochtar
Journal:  Nat New Biol       Date:  1972-03-29

3.  Two genetic variants of von Willebrand's disease.

Authors:  L Holmberg; I M Nilsson
Journal:  N Engl J Med       Date:  1973-03-22       Impact factor: 91.245

4.  Correction of the platelet abnormality in von Willebrand's disease by cryoprecipitate.

Authors:  H J Weiss; J Rogers
Journal:  Am J Med       Date:  1972-12       Impact factor: 4.965

5.  Selective enzyme purification by affinity chromatography.

Authors:  P Cuatrecasas; M Wilchek; C B Anfinsen
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

6.  Immunological differentiation of three types of haemophilia and identification of some female carriers.

Authors:  E Bennett; E R Huehns
Journal:  Lancet       Date:  1970-11-07       Impact factor: 79.321

7.  Factor 8 detection by hemagglutination inhibition: hemophilia A and von Willebrand's disease.

Authors:  D P Stites; E J Hershgold; J D Perlman; H H Fudenberg
Journal:  Science       Date:  1971-01-15       Impact factor: 47.728

8.  Immunologic studies in von Willebrand's disease. Evidence that the antihemophilic factor (AHF) produced after transfusions lacks an antigen associated with normal AHF and the inactive material produced by patients with classic hemophilia.

Authors:  B Bennett; O D Ratnoff; J Levin
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

9.  Immunologic studies of antihemophilic factor (AHF, factor VIII). IV. Radioimmunoassay of AHF antigen.

Authors:  L W Hoyer
Journal:  J Lab Clin Med       Date:  1972-12

10.  Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

Authors:  T S Zimmerman; O D Ratnoff; A E Powell
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

View more
  11 in total

1.  Problems in the detection of carriers of haemophilia A.

Authors:  D Meyer; A Plas; J P Allain; G M Sitar; M J Larrieu
Journal:  J Clin Pathol       Date:  1975-09       Impact factor: 3.411

2.  Factor-VIII-related antigen: multiple molecular forms in human plasma.

Authors:  T S Zimmerman; J Roberts; T S Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

3.  Editorial: The hemophiloid diseases and factor VIII. Clinical molecular biology.

Authors:  T S Edgington
Journal:  West J Med       Date:  1975-05

4.  Medical staff conference: recent chapters in the factor VIII saga--perils of a protein. Fifth annual Paul M. Aggeler Memorial Lecture.

Authors: 
Journal:  West J Med       Date:  1975-05

5.  The properties of immune complexes formed by human antibodies to factor VIII.

Authors:  J Lazarchick; L W Hoyer
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

6.  von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.

Authors:  R R Montgomery; T S Zimmerman
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

Review 7.  Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.

Authors:  Steven W Pipe; Robert R Montgomery; Kathleen P Pratt; Peter J Lenting; David Lillicrap
Journal:  Blood       Date:  2016-09-01       Impact factor: 22.113

8.  Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.

Authors:  H J Weiss; I I Sussman; L W Hoyer
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

9.  Direct characterization of factor VIII in plasma: detection of a mutation altering a thrombin cleavage site (arginine-372----histidine).

Authors:  M Arai; H Inaba; M Higuchi; S E Antonarakis; H H Kazazian; M Fujimaki; L W Hoyer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

10.  The defect in hemophilic and von Willebrand's disease plasmas studied by a recombination technique.

Authors:  H A Cooper; R H Wagner
Journal:  J Clin Invest       Date:  1974-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.